|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Cancer
|
NCI
|
|
|
Other Projects Click here to get detailed project listings
|
|
|
|
$466,258,577
|
|
Cancer
|
NCI
|
1K22CA095326-01
|
|
A Critical Role for Stat2 in Type 1 Intferon-Induced Apoptosis
|
GAMERO, ANA
|
TEMPLE UNIVERSITY
|
PA
|
$162,945
|
|
Cancer
|
NIDDK
|
1U01DK074035-01
|
|
New Diagnosis and Treatment Approaches for Patients wit*
|
MCCALLUM, RICHARD
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$169,454
|
|
Cancer
|
NCI
|
2R44CA105622-02
|
|
Innovative Tools for the Molecular Diagnosis of Cancer
|
HENKENS, ROBERT
|
ALDERON BIOSCIENCES, INC.
|
NC
|
$301,677
|
|
Cancer
|
NCI
|
1R43CA114924-01A2
|
|
Nanoparticles for the Treatment of Lung Cancer
|
CHADA, SUNIL
|
INTROGEN RESEARCH INSTITUTE, INC.
|
TX
|
$234,382
|
|
Cancer
|
NCI
|
4R37CA053394-17
|
|
Mechanism of action of the v-erb A oncogene of AEV.
|
PRIVALSKY, MARTIN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$300,645
|
|
Cancer
|
NCI
|
5R13CA121807-02
|
|
CSHL Conference on PTEN Pathways
|
STEWART, DAVID
|
COLD SPRING HARBOR LABORATORY
|
NY
|
$7,000
|
|
Cancer
|
NCI
|
5R13CA119850-02
|
|
CSHL Conference on the Cell Cycle
|
GRODZICKER, TERRI
|
COLD SPRING HARBOR LABORATORY
|
NY
|
$4,000
|
|
Cancer
|
NCI
|
5R01CA059998-15
|
|
SPROUTY, A WT1 TARGET FOR GROWTH AND DEVELOPMENT
|
LICHT, JONATHAN
|
NORTHWESTERN UNIVERSITY
|
IL
|
$273,189
|
|
Cancer
|
NCI
|
5R01CA113863-03
|
|
The Role of Fragile Sites in RET/PTC Rearrangement
|
WANG, YUH-HWA
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$258,081
|
|
Cancer
|
NCI
|
5R01CA106316-05
|
|
Intervention to Prevent Onset of Smoking in Childhood
|
JACKSON, CHRISTINE
|
RESEARCH TRIANGLE INSTITUTE
|
NC
|
$191,573
|
|
Cancer
|
NCI
|
1R01CA116379-01A1
|
|
3-D Transrectal Ultrasound with 2-D Arrays
|
YEN, JESSE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$248,168
|
|
Cancer
|
NCI
|
1R01CA120958-01A1
|
|
Promoting Tobacco Control Among Teachers in India
|
SORENSEN, GLORIAN
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$623,465
|
|
Cancer
|
NCI
|
1R21CA120204-01A1
|
|
Mammary Tumor Stem Cells
|
PEASTON, ANNE
|
JACKSON LABORATORY
|
ME
|
$234,900
|
|
Cancer
|
NINR
|
1R01NR010939-01A2
|
|
Altered Brain Function in Chemotherapy for Breast Cancer
|
CIMPRICH, BERNADINE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$369,428
|
|
Cancer
|
NCI
|
5R01CA085870-07
|
|
Interaction of uPAR & Integrins in Oral Cancer
|
STACK, MARY
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$224,062
|
|
Cancer
|
NCI
|
5R01CA104922-04
|
|
Phenolic antioxidants as tumor radio/chemosensitizers
|
KOUMENIS, CONSTANTINOS
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$261,121
|
|
Cancer
|
NCI
|
5R01CA114039-04
|
|
Use of Cystatin C to Combat TGF-Beta Tumorigenesis
|
SCHIEMANN, WILLIAM
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$255,871
|
|
Cancer
|
NCI
|
5R13CA108837-04
|
|
RRS Annual Meeting 2004, St. Louis, MO
|
ULLRICH, ROBERT
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$3,000
|
|
Cancer
|
NCI
|
5R01CA102484-05
|
|
Genetic Susceptibility to Arsenic-induced Skin Cancer
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
IL
|
$384,390
|
|
Cancer
|
NIGMS
|
5R01GM068813-03
|
|
VTC Events Mediated by the Rab2 Complex
|
TISDALE, ELLEN
|
WAYNE STATE UNIVERSITY
|
MI
|
$237,671
|
|
Cancer
|
NCI
|
5R01CA082723-09
|
|
K Vitamins- A New Class of Liver Cell Growth Inhibitors
|
CARR, BRIAN
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$263,832
|
|
Cancer
|
NIGMS
|
5R01GM067926-05
|
|
Allosteric Modulation of the Multidrug Transporter MDR1
|
DEY, SAIBAL
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$230,237
|
|
Cancer
|
NCI
|
5R37CA055360-18
|
|
MECHANISMS OF SIGNAL TRANSDUCTION BY RAS PROTEINS
|
BAR-SAGI, DAFNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$470,319
|
|
Cancer
|
NCI
|
5R01CA109262-04
|
|
Regulation of Mdm2 compartmentalization
|
MAYO, LINDSEY
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$226,405
|
|
Cancer
|
NCI
|
5R01CA079892-09
|
|
BRCA1 function in G2-M checkpoint and mitosis
|
OUCHI, TORU
|
EVANSTON NORTHWESTERN HEALTHCARE
|
IL
|
$216,896
|
|
Cancer
|
NCI
|
5K08CA106597-03
|
|
Chromatin structure and BRCA1 Checkpoint Function
|
GREENBERG, ROGER
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$135,677
|
|
Cancer
|
NCI
|
5U01CA114591-04
|
|
WINCART: Weaving an Islander Network for Cancer Control
|
TANJASIRI, SORA
|
CALIFORNIA STATE UNIVERSITY FULLERTON
|
CA
|
$509,769
|
|
Cancer
|
NCI
|
5R13CA100041-03
|
|
2003 Molecular Cell Biology Gordon Conference
|
O'SHEA, ERIN
|
GORDON RESEARCH CONFERENCES
|
RI
|
$5,000
|
|
Cancer
|
NCI
|
5R01CA106728-05
|
|
Melanoma detection by optical spectroscopy
|
WANG, LIHONG
|
WASHINGTON UNIVERSITY
|
MO
|
$325,515
|
|
Cancer
|
NIDDK
|
5R21DK073177-02
|
|
Modeling Novel Gastrointestinal Growth Pathways in the Zebrafish
|
BAHARY, NATHAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$181,200
|
|
Cancer
|
NCI
|
2R01CA086832-06A2
|
|
MOLECULAR DETERMINANTS OF BRAIN-METASTATIC MELANOMA
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$279,192
|
|
Cancer
|
NCI
|
5R13CA124292-02
|
|
Ubiquitin and Cellular Regulation
|
WILKINSON, KEITH
|
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
|
MD
|
$8,000
|
|
Cancer
|
NCI
|
5K08CA116429-03
|
|
Creation of AlkB Mutants for Protection of Bone Marrow
|
CAMPS, MANEL
|
UNIVERSITY OF CALIFORNIA SANTA CRUZ
|
CA
|
$132,532
|
|
Cancer
|
NCI
|
5R13CA124244-02
|
|
Regulation & Function of Small GTPases
|
PHILIPS, MARK
|
FEDERATION OF AMER SOC FOR EXPER BIOLOGY
|
MD
|
$8,000
|
|
Cancer
|
NCI
|
5K01CA118425-03
|
|
Genetic and genomic analysis of Ras signaling in colorectal cancer progression
|
HAIGIS, KEVIN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$162,964
|
|
Cancer
|
NCI
|
5R01CA105139-04
|
|
Dendritic Cell Vaccination During Lymphoid Reconstitution
|
WEBER, JEFFREY
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$603,745
|
|
Cancer
|
NCI
|
5K08CA101954-03
|
|
Chemokine Secreting Dendritic Cells for Glioma Immunotherapy
|
SLOAN, ANDREW
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$135,426
|
|
Cancer
|
NINDS
|
5U01NS050094-03
|
|
Characterizing Beta Lactams as Neuroprotectants for Amyotrophic Lateral Sclerosis
|
ROTHSTEIN, JEFFREY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$322,944
|
|
Cancer
|
NCI
|
5K07CA106225-03
|
|
Affect and Decision-Making for Cancer-Related Behaviors
|
KIVINIEMI, MARC
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$106,722
|
|
Cancer
|
NIAID
|
1K22AI070317-01A1
|
|
Essential role of transcription factor Foxp1 in B cell development and function
|
HU, HUI
|
WISTAR INSTITUTE
|
PA
|
$162,000
|
|
Cancer
|
NCI
|
5R01CA093926-07
|
|
The Regulation of UPA and UPAR in Human Carcinoma Cells
|
HUANG, SHUANG
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$232,554
|
|
Cancer
|
NCI
|
5R13CA110775-04
|
|
Workshop on the Nuclear Radiology of Breast Cancer
|
LEVIN, CRAIG
|
STANFORD UNIVERSITY
|
CA
|
$5,000
|
|
Cancer
|
NIBIB
|
5R13CA110775-04
|
|
Workshop on the Nuclear Radiology of Breast Cancer
|
LEVIN, CRAIG
|
STANFORD UNIVERSITY
|
CA
|
$3,000
|
|
Cancer
|
NCI
|
4R37CA058976-16
|
|
Molecular Analysis of the alpha6beta4 Integrin
|
GIANCOTTI, FILIPPO
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$410,916
|
|
Cancer
|
NCI
|
4R37CA058596-16
|
|
Functional Properties of the Wilms' Tumor Gene WT1
|
HABER, DANIEL
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$436,192
|
|
Cancer
|
NCI
|
4R37CA054281-16
|
|
Multiethnic Cohort Study of Diet and Cancer
|
KOLONEL, LAURENCE
|
UNIVERSITY OF HAWAII AT MANOA
|
HI
|
$2,292,128
|
|
Cancer
|
NCI
|
4R37CA050519-18
|
|
Roles of DNA PK in DNA Double Strand Break Repair
|
CHEN, DAVID
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$398,639
|
|
Cancer
|
NCI
|
4R37CA017542-33
|
|
Genetics of RNA Tumor Viruses
|
MARTIN, G
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
CA
|
$508,803
|
|
Cancer
|
NCI
|
5R01CA057569-17
|
|
Isolation of genes for radiation sensitivity
|
CONCANNON, PATRICK
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$299,141
|
|
Cancer
|
NCI
|
5R13CA110321-03
|
|
2004 Growth Factor Signalling Gordon Conference
|
YAFFE, MICHAEL
|
GORDON RESEARCH CONFERENCES
|
RI
|
$5,000
|
|
Cancer
|
NCI
|
5R01CA110249-03
|
|
Antigen processing and HLA-peptide complexes in head and neck cancer
|
FERRONE, SOLDANO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$318,336
|
|
Cancer
|
NCI
|
5R01CA090833-07
|
|
Stem cell manipulation via HOX gene regulation
|
EMERSON, STEPHEN
|
HAVERFORD COLLEGE
|
PA
|
$280,779
|
|
Cancer
|
NCI
|
5R13CA110143-03
|
|
International Congresses - Metastasis Research Society
|
WELCH, DANNY
|
METASTASIS RESEARCH SOCIETY
|
AL
|
$21,000
|
|
Cancer
|
NCI
|
5R01CA063640-12
|
|
Breast Cancer Biology of Translational De-repression
|
HAGEDORN, CURT
|
UNIVERSITY OF UTAH
|
UT
|
$237,241
|
|
Cancer
|
NCI
|
4R37CA046595-22
|
|
Mitogenic and Oncogenic Regulation of ERK/RSK Signaling
|
BLENIS, JOHN
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$683,560
|
|
Cancer
|
NCI
|
5R01CA079736-08
|
|
Role of Maspin in Breast Cancer Progression
|
ZHANG, MING
|
NORTHWESTERN UNIVERSITY
|
IL
|
$293,242
|
|
Cancer
|
NCI
|
5F31CA117058-03
|
|
Minority Predoctoral Fellowship Program
|
PARTRIDGE, JUNETH ANN
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$29,499
|
|
Cancer
|
NIGMS
|
5F32GM078852-02
|
|
Effect of Chromokinesins on Spindle Microtubule Dynamics
|
HOUGHTALING, BENJAMIN
|
ROCKEFELLER UNIVERSITY
|
NY
|
$45,976
|
|
Cancer
|
NHLBI
|
5R01HL082672-03
|
|
Impact of Obesity and Sleep Disorders on Health
|
KRYGER, MEIR
|
GAYLORD HOSPITAL, INC.
|
CT
|
$164,784
|
|
Cancer
|
NIGMS
|
5F32GM078840-02
|
|
Role of Sgs1, yeast Werner/Bloom homologue in DNA repair
|
BERNSTEIN, KARA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$45,976
|
|
Cancer
|
NCI
|
5R13CA110769-03
|
|
CAARI 2004: 18th Int'l Conf of Accelerators in Research
|
MCDANIEL, FLOYD
|
UNIVERSITY OF NORTH TEXAS
|
TX
|
$5,000
|
|
Cancer
|
NCI
|
5R13CA124279-02
|
|
11th & 12th Conference on Cancer Therapy with Antibodies and Immunoconjugates
|
GOLDENBERG, DAVID
|
CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY
|
NJ
|
$5,000
|
|
Cancer
|
NCI
|
2T32CA009695-16
|
|
Advanced Techniques for Cancer Imaging and Detection
|
GLAZER, GARY
|
STANFORD UNIVERSITY
|
CA
|
$142,062
|
|
Cancer
|
NCI
|
5R21CA120141-02
|
|
Native Vision Tobacco Coalition's Community Partnered Research
|
MCPHERON-KEEL, THEDA
|
NATIVE AMERICAN COMMUNITY HEALTH CENTER
|
AZ
|
$104,653
|
|
Cancer
|
NCI
|
1K22CA128616-01
|
|
Thrombospondin-1 Regulates Vascular Tone
|
ISENBERG, JEFFREY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$153,063
|
|
Cancer
|
NCI
|
1R21CA125698-01A1
|
|
Surrogate and Sentinal Technologies to Monitor Stability of Cancer Phosphoprotein
|
LIOTTA, LANCE
|
GEORGE MASON UNIVERSITY
|
VA
|
$179,404
|
|
Cancer
|
NIEHS
|
5R01ES015323-03
|
|
Role of p53 and ptc tumor suppressive pathways in BCCs development and prevention
|
ATHAR, MOHAMMAD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$319,725
|
|
Cancer
|
NCI
|
5R01MH063172-05
|
|
Risk of Major Depression Among Breast Cancer Patients
|
COYNE, JAMES
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$97,100
|
|
Cancer
|
NIMH
|
5R01MH063172-05
|
|
Risk of Major Depression Among Breast Cancer Patients
|
COYNE, JAMES
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$503,206
|
|
Cancer
|
NIDDK
|
5F32DK077424-02
|
|
Histone methylation and transcriptional by the menin tumor suppresor
|
FRANCIS, JOSHUA
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$45,976
|
|
Cancer
|
NIGMS
|
5F32GM078776-02
|
|
The Role of Dab2 in EGFR Endocytosis
|
TECKCHANDANI, ANJALI
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$45,976
|
|
Cancer
|
NCI
|
5U01CA122171-03
|
|
Genomewide association in early-onset breast cancer
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
IL
|
$1,170,110
|
|
Cancer
|
NIGMS
|
5F32GM076869-02
|
|
Chemical Biology of BubR1
|
SANDLER, JOEL
|
ROCKEFELLER UNIVERSITY
|
NY
|
$45,976
|
|
Cancer
|
NIDDK
|
5F32DK077469-02
|
|
Obesity and regulation of energy homeostasis in Drosophila melanogaster
|
FORSTHOEFEL, DAVID
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$48,796
|
|
Cancer
|
NCI
|
5F31CA123645-02
|
|
MINORITY PREDOCTORAL FELLOWSHIP PROGRAM
|
MILLER, CLAUDIA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$24,404
|
|
Cancer
|
NIAID
|
5R01AI068900-02
|
|
Lymphoid Tissue Microvessel Growth
|
LU, THERESA
|
HOSPITAL FOR SPECIAL SURGERY
|
NY
|
$385,901
|
|
Cancer
|
NIGMS
|
5R37GM021422-32
|
|
ERROR CORRECTION IN DNA SYNTHESIS--A BIOCHEMICAL STUDY
|
GOODMAN, MYRON
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$392,336
|
|
Cancer
|
NCI
|
1R21CA114279-01A2
|
|
MRI Assessment of Anti-angiogenesis in Mouse Gliomas
|
PIKE, MARTIN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$173,250
|
|
Cancer
|
NCI
|
2R01CA097022-06
|
|
Survival Mechanisms of Invasive Carcinoma Cells
|
KLEMKE, RICHARD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$283,260
|
|
Cancer
|
NCI
|
4R37CA042245-23
|
|
Regulation of replication and latency EBV EBNAs
|
HAYWARD, S
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$367,373
|
|
Cancer
|
NIEHS
|
5R01ES015339-02
|
|
Protein Kinase Signaling and Cell Cycle Control
|
YAFFE, MICHAEL
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$352,978
|
|
Cancer
|
NIEHS
|
5R01ES015252-02
|
|
Molecular Basis of BRCA2-mediated DNA Repair and Cancer Avoidance
|
SUNG, PATRICK
|
YALE UNIVERSITY
|
CT
|
$359,887
|
|
Cancer
|
NIEHS
|
5R01ES014626-02
|
|
Regulation of Sulfotransferases by LXR and its Implication in Pathophysiology
|
XIE, WEN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$308,157
|
|
Cancer
|
NIEHS
|
5R01ES011344-12
|
|
Mouse Models of DNA Repair - Defective Human Diseases
|
FRIEDBERG, ERROL
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$346,185
|
|
Cancer
|
NCI
|
5F31CA123711-02
|
|
Targeting ATF5 for intervention in brain cancer
|
ARIAS, ANGELO
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$30,513
|
|
Cancer
|
NCI
|
5F31CA126523-02
|
|
Contributions of Epstein-Barr Virus EBNA2 and EBNA-LP to B cell immortalization
|
ECHENDU, CHISAROKA
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$35,140
|
|
Cancer
|
NCI
|
5R01CA056821-15
|
|
Immunization Against Melanoma Differentiation Antigens
|
HOUGHTON, ALAN
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$294,335
|
|
Cancer
|
NCI
|
5R01CA113482-03
|
|
Cell Therapy of Refractory Leukemia
|
CAMPANA, DARIO
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$286,536
|
|
Cancer
|
NCI
|
5R01CA076560-07
|
|
Thymidylate Synthases: Modes of Catalysis and Inhibition
|
LEBIODA, LUKASZ
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
SC
|
$163,827
|
|
Cancer
|
NCI
|
5R01CA118940-03
|
|
Astatine-211 Conditioning for Nonmyeloablative Hematopoietic Stem Cell Allografts
|
SANDMAIER, BRENDA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$286,369
|
|
Cancer
|
NCI
|
5R01CA113797-03
|
|
Targeted Alpha-Particle Emitter Therapy of Metastases
|
SGOUROS, GEORGE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$278,677
|
|
Cancer
|
NCI
|
7R01CA106673-04
|
|
Macrocyclic Enyne Methathesis and Its Applications
|
LEE, DAESUNG
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$244,138
|
|
Cancer
|
NCI
|
5R01CA080066-10
|
|
Pak1 - PIN Pathway in Breast Cancer Progression
|
KUMAR, RAKESH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$257,716
|
|
Cancer
|
NCI
|
5R01CA112175-03
|
|
ENHANCED APOPTOSIS BY TARGETING PROTEIN REDOX STATUS
|
NATARAJAN, MOHAN
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$174,209
|
|
Cancer
|
NCI
|
5R01CA059750-13
|
|
TOPOISOMERASE I AS AN ANTITUMOR DRUG TARGET
|
CUTLER, MARY
|
HENRY M. JACKSON FDN FOR THE ADV MIL/MED
|
MD
|
$223,560
|
|
Cancer
|
NCI
|
5R01CA114277-03
|
|
Predicting Metastasis in Melanoma
|
RIMM, DAVID
|
YALE UNIVERSITY
|
CT
|
$253,616
|
|
Cancer
|
NCI
|
5R01CA100905-05
|
|
Accessibilty Control of Antigen Receptor Gene Assembly
|
OLTZ, EUGENE
|
VANDERBILT UNIVERSITY
|
TN
|
$331,119
|
|
Cancer
|
NHGRI
|
5U54HG003079-05
|
|
Center For Large-Scale Genome Sequencing & Analysis
|
WILSON, RICHARD
|
WASHINGTON UNIVERSITY
|
MO
|
$34,501,449
|
|
Cancer
|
NCI
|
5R01CA085492-08
|
|
TGF-Beta Suppression and Promotion of Mammary Carcinomas
|
MOSES, HAROLD
|
VANDERBILT UNIVERSITY
|
TN
|
$441,398
|
|
Cancer
|
NCI
|
5R01CA040489-23
|
|
Pathogenesis of Hepatitis B Virus in Transgenic Mice
|
CHISARI, FRANCIS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$792,726
|
|
Cancer
|
NCI
|
2R01CA098779-07
|
|
CAV-1, Stat5a Signaling, and Estrogen-Dependent Breast Cancer
|
LISANTI, MICHAEL
|
THOMAS JEFFERSON UNIVERSITY
|
PA
|
$336,271
|
|
Cancer
|
NCI
|
5R01CA107263-05
|
|
Integrins and Caspase 8 in Neuroblastoma Progression
|
STUPACK, DWAYNE
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$300,314
|
|
Cancer
|
NIAID
|
5R01AI058057-05
|
|
Function of the gammaHV68 M2 Antigen
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
GA
|
$353,697
|
|
Cancer
|
NCI
|
5R01CA030645-27
|
|
Glycosylation Mutants of Mice and Animal Cells
|
STANLEY, PAMELA
|
YESHIVA UNIVERSITY
|
NY
|
$508,261
|
|
Cancer
|
NIAID
|
2R01AI020001-25
|
|
Pathogenesis of Liver Disease in Hepatitis
|
CHISARI, FRANCIS
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$685,357
|
|
Cancer
|
NIGMS
|
5R01GM053960-11
|
|
DNA Lesions as Endogenous Topoisomerase Poisons
|
OSHEROFF, NEIL
|
VANDERBILT UNIVERSITY
|
TN
|
$281,473
|
|
Cancer
|
NIGMS
|
5R01GM062917-07
|
|
Establishment of Epithelial Planar Cell Polarity
|
MLODZIK, MAREK
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$370,315
|
|
Cancer
|
NCI
|
5R01CA064430-13
|
|
Deciphering how MdmX deregulation impacts the p53 pathway
|
BERBERICH, STEVEN
|
WRIGHT STATE UNIVERSITY
|
OH
|
$215,084
|
|
Cancer
|
NCI
|
5R01CA045957-21
|
|
The IL-2 receptor in T regulatory cell development
|
MALEK, THOMAS
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$294,823
|
|
Cancer
|
NCI
|
5R01CA028868-27
|
|
Carcinogen Activation and Screening in Variant Cells
|
HANKINSON, OLIVER
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$324,370
|
|
Cancer
|
NIGMS
|
5R01GM049883-15
|
|
Genetic and Molecular Studies of Drosophila Chromatin Remodeling Factors
|
TAMKUN, JOHN
|
UNIVERSITY OF CALIFORNIA SANTA CRUZ
|
CA
|
$298,121
|
|
Cancer
|
NCI
|
5R01CA106258-05
|
|
Mechanisms of human T-cell immortalization by HTLV-I Tax
|
NICOT, CHRISTOPHE
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
KS
|
$219,529
|
|
Cancer
|
NCI
|
5R01CA117821-08
|
|
PGE2 Receptor Function in Skin
|
PENTLAND, ALICE
|
UNIVERSITY OF ROCHESTER
|
NY
|
$287,986
|
|
Cancer
|
NIEHS
|
5F32ES014777-02
|
|
Role of estrogen receptor beta in cancer prevention by dietary indole-3-carbinol
|
BENNINGHOFF, ABBY
|
OREGON STATE UNIVERSITY
|
OR
|
$24,398
|
|
Cancer
|
NCI
|
5R01CA018138-32
|
|
Mammalian Polyamine Metabolism
|
PEGG, ANTHONY
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$313,665
|
|
Cancer
|
NCI
|
5R01CA042978-22
|
|
Biological activity of ras oncogenes
|
DER, CHANNING
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$319,853
|
|
Cancer
|
NCI
|
5R01CA082481-09
|
|
The Molecular Basis of Telomerase Function & Regulation
|
COUNTER, CHRISTOPHER
|
DUKE UNIVERSITY
|
NC
|
$295,691
|
|
Cancer
|
NCI
|
5R01CA085935-08
|
|
Tubulin Mutations and Paclitaxel Resistance
|
CABRAL, FERNANDO
|
UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
|
TX
|
$263,242
|
|
Cancer
|
NCI
|
5R01CA114567-03
|
|
Targeted therapy in ex vivo medulloblastoma/PNET
|
OLSON, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$223,417
|
|
Cancer
|
NIDDK
|
5R01DK054909-09
|
|
PKC ISOZYMES AND INTESTINAL EPITHELIAL GROWTH CONTROL
|
BLACK, JENNIFER
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$268,069
|
|
Cancer
|
NCI
|
5R01CA107023-04
|
|
Anti-TfR IgG3-Av: A New Drug Against Multiple Myeloma
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$300,313
|
|
Cancer
|
NCI
|
5R01CA026869-29
|
|
PROGESTERONE RECEPTORS AND BREAST CANCER
|
HORWITZ, KATHRYN
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$398,776
|
|
Cancer
|
NCI
|
5R01CA080095-10
|
|
TGF beta-induced apoptosis in B-lymphocytes
|
HOWE, PHILIP
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$261,130
|
|
Cancer
|
NIAID
|
5R01AI057947-05
|
|
IKK Signals in Lymphocyte Physiology and Pathology
|
RAJEWSKY, KLAUS
|
IMMUNE DISEASE INSTITUTE, INC.
|
MA
|
$439,502
|
|
Cancer
|
NCI
|
5R01CA083962-09
|
|
The Biology of Promyelocytic Leukemia in a Mouse Model
|
LEY, TIMOTHY
|
WASHINGTON UNIVERSITY
|
MO
|
$403,533
|
|
Cancer
|
NCI
|
5R01CA081310-07
|
|
Effect of Oxidant Load on HPV Persistence and CIN (SIL)
|
GIULIANO, ANNA
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$459,600
|
|
Cancer
|
NIGMS
|
5R01GM054996-10
|
|
Mechanistic Studies of Nucleic Acid Damage and Their Application
|
GREENBERG, MARC
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$315,217
|
|
Cancer
|
NCI
|
5R33CA114306-03
|
|
Tadpole Assays for the Molecular Assessment of Cancer
|
BRENT, ROGER
|
MOLECULAR SCIENCES INSTITUTE
|
CA
|
$240,776
|
|
Cancer
|
NCI
|
5R01CA115707-02
|
|
Targeting Notch3 in Lung Cancer
|
DANG, THAO
|
VANDERBILT UNIVERSITY
|
TN
|
$262,485
|
|
Cancer
|
NIGMS
|
5R37GM032741-26
|
|
INTRACHROMOSOMAL RECOMBINATION IN MAMMALIAN CELLS
|
LISKAY, R
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$354,186
|
|
Cancer
|
NIGMS
|
5R01GM052216-12
|
|
Arsenate resistance in prokaryotes and eukaryotes
|
ROSEN, BARRY
|
WAYNE STATE UNIVERSITY
|
MI
|
$227,147
|
|
Cancer
|
NIAID
|
5R01AI064844-03
|
|
Role of Hepatitis B virus X protein in HBV replication.
|
BOUCHARD, MICHAEL
|
DREXEL UNIVERSITY
|
PA
|
$315,019
|
|
Cancer
|
NCI
|
5R13CA119860-03
|
|
Annual San Antonio Breast Cancer Symposium
|
COLTMAN, CHARLES
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$5,000
|
|
Cancer
|
NIAID
|
5R01AI056082-03
|
|
ST6Gal Sialyltransferase in Innate and Adaptive Immune Response
|
LAU, JOSEPH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$355,273
|
|
Cancer
|
NIGMS
|
5R01GM053050-13
|
|
Cell Cycle Checkpoint that Monitors Morphogenesis
|
LEW, DANIEL
|
DUKE UNIVERSITY
|
NC
|
$328,545
|
|
Cancer
|
NCI
|
5R01CA112310-04
|
|
Role of Raf Kinase Inhibitory Protein in Prostate Cancer
|
ROSNER, MARSHA
|
UNIVERSITY OF CHICAGO
|
IL
|
$297,116
|
|
Cancer
|
NCI
|
5F32CA125984-02
|
|
Modeling Breast Carcinoma In Situ: Implications for Prevention and Control
|
STOUT, NATASHA
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
MA
|
$50,428
|
|
Cancer
|
NCI
|
5R01CA115965-02
|
|
FHIT Gene Therapy in Cancer Prevention and Treatment
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
OH
|
$228,000
|
|
Cancer
|
NCI
|
5R01CA118261-03
|
|
Molecular Requirements for Recombinant Cytotoxins Efficacy
|
DEBINSKI, WALDEMAR
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$243,842
|
|
Cancer
|
NCI
|
5R01CA077427-07
|
|
Strategies of Vaccination Against MUC.1 Antigen
|
ZANETTI, MAURIZIO
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$243,546
|
|
Cancer
|
NCI
|
5R01CA121137-03
|
|
Molecular Oncogenic Properties of Mutant p53
|
CHEN, XINBIN
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$288,800
|
|
Cancer
|
NHLBI
|
5K99HL088021-02
|
|
Impact of Comorbidities on Outcomes of Allogeneic Transplantation
|
SORROR, MOHAMED
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$88,973
|
|
Cancer
|
NCI
|
5R01CA107311-04
|
|
Polyamide-Chl inhibition of cancer cell proliferation
|
GOTTESFELD, JOEL
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$533,302
|
|
Cancer
|
NCI
|
5R01CA100925-04
|
|
Role of P80 pro-IL-16 in T Cell Malignancy
|
ZHANG, YUJUN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$282,526
|
|
Cancer
|
NCI
|
5R01CA069212-13
|
|
IP-10 Chemokine: Role in T Cell Recruitment and Disease
|
LUSTER, ANDREW
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$398,381
|
|
Cancer
|
NIGMS
|
5R01GM029006-27
|
|
Function And Mechanism Of DNA Topoisomerase
|
HSIEH, TAO-SHIH
|
DUKE UNIVERSITY
|
NC
|
$523,245
|
|
Cancer
|
NCI
|
5K99CA126173-02
|
|
Roles of the Checkpoint Kinase Chk1 in Cancer Biology and Therapy
|
ZHANG, YOU-WEI
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
CA
|
$96,874
|
|
Cancer
|
NCI
|
5R01CA112438-03
|
|
Breaking tolerance to mEGP self-antigen
|
HERLYN, DOROTHEE
|
WISTAR INSTITUTE
|
PA
|
$197,513
|
|
Cancer
|
NCI
|
5R01CA121327-02
|
|
Molecular Basis Of Renal Cell Carcinoma Response to SU11428
|
MOTZER, ROBERT
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$346,940
|
|
Cancer
|
NCI
|
7K99CA125937-02
|
|
Characterization of prostatic stem cells and prostate cancer-initiating cells
|
XIN, LI
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$89,179
|
|
Cancer
|
FIC
|
5R03TW007170-02
|
|
Runx1 Binding Sites as Scaffolds That Mediate Chromosome Translocation
|
STEIN, JANET
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$39,372
|
|
Cancer
|
NCI
|
5R01CA113636-03
|
|
Sleeping Beauty for uncovering cancer genes in mice
|
LARGAESPADA, DAVID
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$257,668
|
|
Cancer
|
NIDDK
|
5F32DK075230-02
|
|
Biology of EGFR and P53 in esophageal epithelial cells
|
MICHAYLIRA, CARMEN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$48,796
|
|
Cancer
|
NIGMS
|
5R01GM029028-25
|
|
Synthesis of Bioactive Natural Products
|
SMITH, AMOS
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$279,739
|
|
Cancer
|
NIGMS
|
5R01GM052872-10
|
|
Regulation of RNA metabolism and cell growth control by SR protein kinases
|
FU, XIANG-DONG
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$318,708
|
|
Cancer
|
NIGMS
|
5R01GM050898-13
|
|
Mitotic Response to DNA damage
|
THEURKAUF, WILLIAM
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$499,975
|
|
Cancer
|
NHLBI
|
5R01HL049094-15
|
|
Cyclooxygenase-2 Regulation and Function
|
HLA, TIMOTHY
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
CT
|
$338,724
|
|
Cancer
|
NCI
|
5R01CA120196-02
|
|
Mechanisms of T-Cell Leukemogenesis Induced by Notch1
|
FERRANDO, ADOLFO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$305,900
|
|
Cancer
|
NIAID
|
5K23AI067567-03
|
|
Rebuilding immunity
|
AQUI, NICOLE
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$133,029
|
|
Cancer
|
NIEHS
|
5R01ES007800-12
|
|
Ah Receptor Anatomy: Implications for Dioxin Toxicity
|
ELFERINK, CORNELIS
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
TX
|
$330,706
|
|
Cancer
|
NCI
|
5R01CA124648-02
|
|
An integrative approach to cancer gene discovery in hepatocellular carcinoma
|
POWERS, SCOTT
|
COLD SPRING HARBOR LABORATORY
|
NY
|
$419,084
|
|
Cancer
|
NCI
|
5U01CA062405-14
|
|
NABTC Member Institution Grant (UCSF Project Leader)
|
LIEBERMAN, FRANK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$58,706
|
|
Cancer
|
NCI
|
5R01CA116093-02
|
|
Effects of human SWI/SNF-associated PRMT5 on lymphomagenesis
|
SIF, SAID
|
OHIO STATE UNIVERSITY
|
OH
|
$256,500
|
|
Cancer
|
NCI
|
5R01CA112337-04
|
|
Colon Cancer Inhibition by a Class of PPARgamma Agonists
|
SAFE, STEPHEN
|
TEXAS A&M UNIVERSITY SYSTEM
|
TX
|
$226,255
|
|
Cancer
|
NIGMS
|
5R01GM063587-07
|
|
RE-ENGINEERING THE DIAMETER OF THE DOULBE HELIX
|
KOOL, ERIC
|
STANFORD UNIVERSITY
|
CA
|
$279,293
|
|
Cancer
|
NCI
|
5R01CA107972-04
|
|
Survival Signaling After Genotoxic Insult
|
CERYAK, SUSAN
|
GEORGE WASHINGTON UNIVERSITY
|
DC
|
$237,918
|
|
Cancer
|
NCI
|
5R01CA120960-02
|
|
Functional and Clinical Analysis of Rak in Breast Cancer Suppression
|
LIN, SHIAW-YIH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$263,340
|
|
Cancer
|
NCI
|
5R01CA124621-02
|
|
Role of Arsenic Trioxide in Primary Effusion Lymphoma
|
CHAUDHARY, PREET
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$278,353
|
|
Cancer
|
NCI
|
5R01CA033895-26
|
|
Glycoproteins in Neural Cells and Cancer
|
FUKUDA, MINORU
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
CA
|
$318,067
|
|
Cancer
|
NCI
|
5R01CA094076-07
|
|
ROLE OF ENZYME INDUCTION IN CANCER CHEMOPREVENTION
|
KENSLER, THOMAS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$412,459
|
|
Cancer
|
NCI
|
5R01CA057692-16
|
|
HYPOXIC STRESS MECHANISMS IN RADIATION AND CHEMOTHERAPY
|
MURPHY, BRIAN
|
SRI INTERNATIONAL
|
CA
|
$336,649
|
|
Cancer
|
NICHD
|
5K99HD055052-02
|
|
Epigenetic Regulation of Germ Cell Differentiation from a Stem Cell Lineage
|
CHEN, XIN
|
STANFORD UNIVERSITY
|
CA
|
$7,500
|
|
Cancer
|
NCI
|
5R01CA106655-04
|
|
Analysis of Intracellular Drug Sequestration
|
KRISE, JEFFREY
|
UNIVERSITY OF KANSAS LAWRENCE
|
KS
|
$205,489
|
|
Cancer
|
NIAID
|
1R13AI075650-01
|
|
Keystone Symposium on Lymphocyte Activation and Signaling
|
ROBERTSON, ANDREW
|
KEYSTONE SYMPOSIA
|
CO
|
$10,000
|
|
Cancer
|
NCI
|
1R43CA114876-01A2
|
|
Botanical-derived drug discovery for cancer therapy
|
NORRIS, ANDREW
|
BCN BIOSCIENCES, LLC
|
CA
|
$130,207
|
|
Cancer
|
NIAID
|
5R01AI062888-04
|
|
DC-mediated Homeostatic Prolif. of CD4 T Cells by TSLP
|
LIU, YONG-JUN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$280,910
|
|
Cancer
|
NIEHS
|
5R01ES012720-04
|
|
Gonadal vs. Genomic Influences on Xenobiotic Metabolism
|
VAN WINKLE, LAURA
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$234,813
|
|
Cancer
|
NCI
|
5U01CA062432-14
|
|
NEW APPLICATIONS IN BRAIN TUMOR THERAPY
|
MIKKELSEN, TOM
|
HENRY FORD HEALTH SYSTEM
|
MI
|
$131,442
|
|
Cancer
|
NIGMS
|
5R01GM061851-06
|
|
Targeted Drug Delivery to Surface Receptors
|
SZOKA, FRANCIS
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$272,664
|
|
Cancer
|
NIGMS
|
5R01GM062444-07
|
|
Using Dendrimers to Design Multivalent Therapeutic Agents
|
CLONINGER, MARY
|
MONTANA STATE UNIVERSITY (BOZEMAN)
|
MT
|
$277,395
|
|
Cancer
|
NIGMS
|
5R01GM061126-08
|
|
O-Glycosylation of Epidermal Growth Factor-like modules
|
HALTIWANGER, ROBERT
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$293,936
|
|
Cancer
|
FIC
|
5R03TW007440-02
|
|
The modulation of PCNA ubiquitination by p21 and its significance for DNA repair
|
PRIVES, CAROL
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
NY
|
$39,372
|
|
Cancer
|
NIGMS
|
5F31GM073562-03
|
|
PREDOCTORAL FELLOWSHIPS FOR STUDENTS WITH DISABILITIES
|
TRBOVICH, JAMES
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$27,182
|
|
Cancer
|
NCI
|
5R01CA069202-13
|
|
Structure/Function of Protein Tyrosine Phosphatases
|
ZHANG, ZHONG-YIN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$301,759
|
|
Cancer
|
NCI
|
5R01CA116620-02
|
|
Mechanisms of ATF3-induced mammary tumorigenesis
|
MACLEOD, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$292,600
|
|
Cancer
|
NIGMS
|
5R01GM067958-05
|
|
Molecular Pharmacology of Sphingosine 1-Phosphate
|
LYNCH, KEVIN
|
UNIVERSITY OF VIRGINIA CHARLOTTESVILLE
|
VA
|
$329,812
|
|
Cancer
|
NCI
|
5R01CA112176-04
|
|
Progression and regression of mammary preneoplasia
|
FURTH, PRISCILLA
|
GEORGETOWN UNIVERSITY
|
DC
|
$271,505
|
|
Cancer
|
NIDDK
|
5R01DK048252-15
|
|
Pathophysiology of Distal Tyrosine Pathway Disorders
|
GROMPE, MARKUS
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$308,500
|
|
Cancer
|
NIGMS
|
5R37GM044154-19
|
|
ENZYMES IN ORGANIC SYNTHESIS
|
WONG, CHI-HUEY
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$438,548
|
|
Cancer
|
NCI
|
5R01CA100060-04
|
|
DNA replication, DNA repair and microsatellite stability
|
ECKERT, KRISTIN
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$278,669
|
|
Cancer
|
NCI
|
5R01CA100266-03
|
|
Tumor Suppressors in Lymphocytes
|
WABL, MATTHIAS
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$265,854
|
|
Cancer
|
NIGMS
|
1R43GM079892-01A1
|
|
Phosphane Functionalized Diblock Copolymers for Targeted siRNA Delivery
|
GUIRE, PATRICK
|
INNOVATIVE SURFACE TECHNOLOGIES, LLC
|
MN
|
$99,857
|
|
Cancer
|
NCI
|
5R01CA106532-04
|
|
Complex ganglioside function in neuroblastoma
|
LADISCH, STEPHAN
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$247,903
|
|
Cancer
|
NCI
|
5R01CA106662-04
|
|
Dendritic Cell Threapy for Cutaneous T-Cell Lymphoma
|
FALO, LOUIS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$288,651
|
|
Cancer
|
NIMH
|
5R01MH067916-05
|
|
Control of Cerebellar Development by FGF signaling
|
WECHSLER-REYA, ROBERT
|
DUKE UNIVERSITY
|
NC
|
$295,691
|
|
Cancer
|
NCI
|
5R01CA071669-10
|
|
The Significance of MARCO Expression by Tumor-Pulsed Dendritic Cells
|
MULE, JAMES
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$366,750
|
|
Cancer
|
NCI
|
5R01CA115465-02
|
|
Syk and associated proteins in breast cancer
|
GEAHLEN, ROBERT
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
IN
|
$253,034
|
|
Cancer
|
NCI
|
5R33CA118696-03
|
|
Microarray Platform for Profiling Cancer Proteases
|
CRAVATT, BENJAMIN
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$368,009
|
|
Cancer
|
NCI
|
5U01CA062426-14
|
|
Phase I/I I PK/PD Studies of Agents for CNS Malignancies (NABTC PK Center)
|
KUHN, JOHN
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$183,840
|
|
Cancer
|
NCI
|
5R01CA102325-04
|
|
cPLA2, COX-2 and PPAR-gamma in Cholangiocarcinoma
|
WU, TONG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$224,802
|
|
Cancer
|
NHLBI
|
5F32HL082435-03
|
|
Impact of Vitamin D on Heart Disease and Total Mortality
|
CHAN, JACQUELINE
|
LOMA LINDA UNIVERSITY
|
CA
|
$58,803
|
|
Cancer
|
NIDDK
|
5K08DK073282-03
|
|
Gnotobiotic mouse models/microbial regulation of intestinal injury
|
CRAWFORD, PETER
|
WASHINGTON UNIVERSITY
|
MO
|
$121,138
|
|
Cancer
|
NIDDK
|
5R37DK047556-14
|
|
HEPARIN-BINDING EGF-LIKE FACTORS IN PROSTATE GROWTH
|
FREEMAN, MICHAEL
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$361,146
|
|
Cancer
|
NIGMS
|
5R01GM062891-08
|
|
SKN-1 Regulation and Oxidative Stress Resistance in C. elegans
|
BLACKWELL, THOMAS
|
JOSLIN DIABETES CENTER
|
MA
|
$348,162
|
|
Cancer
|
NCI
|
5R01CA120381-02
|
|
A Mediterranean Diet in for Colon Cancer Prevention
|
DJURIC, ZORA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$367,050
|
|
Cancer
|
NCI
|
5U01CA062474-14
|
|
NEW APPROACHES TO BRAIN TUMOR THERAPY-(NABTT)
|
BREM, HENRY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$119,036
|
|
Cancer
|
NCI
|
5F31CA113285-04
|
|
Mechanism of ART-27 Function in Prostate Cancer
|
NWACHKWU, JEROME
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$46,864
|
|
Cancer
|
NCI
|
5F31CA117049-03
|
|
Minority Predoctoral Fellowship Program
|
OLABISI, OYENIKE
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$29,328
|
|
Cancer
|
NIBIB
|
5R01EB002065-21
|
|
Regulation of tissue repair
|
CHEN, WEN-TIEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$329,124
|
|
Cancer
|
NCI
|
5F31CA113268-03
|
|
HTS for Small Molecule Inhibitors of the RhoA Pathway
|
EVELYN, CHRIS
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$32,641
|
|
Cancer
|
NCI
|
5F31CA110210-04
|
|
In vitro evaluation of uranium estrogenicity
|
RAYMOND-WHISH, STEFANIE
|
NORTHERN ARIZONA UNIVERSITY
|
AZ
|
$27,993
|
|
Cancer
|
NCI
|
5R01CA080942-08
|
|
Structural biology of kinase signaling in T-cells
|
ECK, MICHAEL
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$256,000
|
|
Cancer
|
NCI
|
5R01CA124533-02
|
|
Modulation of skin cancer by PPARBeta/delta
|
PETERS, JEFFREY
|
PENNSYLVANIA STATE UNIVERSITY-UNIV PARK
|
PA
|
$242,020
|
|
Cancer
|
NCI
|
5U01CA062407-14
|
|
Therapeutics Studies of Primary CNS Malignancies
|
WEN, PATRICK
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$142,136
|
|
Cancer
|
NCI
|
7R01CA120244-02
|
|
Oncogene c-Myc-dependent pathways in cutaneous melanoma
|
NIKIFOROV, MIKHAIL
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$318,635
|
|
Cancer
|
NCI
|
5R01CA082036-09
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$443,347
|
|
Cancer
|
NCI
|
5R01CA084628-16
|
|
Telomerase in Development, Senescence and Neoplasia
|
DEPINHO, RONALD
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$578,964
|
|
Cancer
|
NCI
|
5R01CA119200-02
|
|
Optical Imaging of Ovarian Carcinogenesis in a Rat Menopause Model
|
BARTON, JENNIFER
|
UNIVERSITY OF ARIZONA
|
AZ
|
$282,857
|
|
Cancer
|
NCI
|
1R13CA130251-01
|
|
Regulatory Mechanisms in Eukaryotic Transcription
|
ROBERTSON, ANDREW
|
KEYSTONE SYMPOSIA
|
CO
|
$10,000
|
|
Cancer
|
NCI
|
1R13CA130252-01
|
|
Keystone Meeting on Cell Death and Cellular Senescence
|
ROBERTSON, ANDREW
|
KEYSTONE SYMPOSIA
|
CO
|
$3,000
|
|
Cancer
|
NCI
|
5R01CA106468-04
|
|
Functional role of p130Cas/BCAR1 in breast cancer
|
KIRSCH, KATHRIN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$282,526
|
|
Cancer
|
NCI
|
5R01CA043122-20
|
|
The Functions of Epstein Barr Virus Nuclear Antigen 1
|
YATES, JOHN
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$307,540
|
|
Cancer
|
NCI
|
5R01CA036327-25
|
|
N-Ras Signaling in Tumorigenesis and Physiology
|
PELLICER, ANGEL
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$458,935
|
|
Cancer
|
NCI
|
5R01CA042368-23
|
|
Investigation of integrin alpha6beta4 microdomain functions
|
HEMLER, MARTIN
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$285,031
|
|
Cancer
|
NCI
|
5R01CA105412-05
|
|
Transmembrane Proteins Involved in Human Tumor Expansion
|
QUIGLEY, JAMES
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$331,509
|
|
Cancer
|
NCI
|
5R01CA077593-07
|
|
Phenotypic Plasticity in Human Neuroblastoma
|
ROSS, ROBERT
|
FORDHAM UNIVERSITY
|
NY
|
$239,931
|
|
Cancer
|
NCI
|
5R37CA037392-27
|
|
CHARACTERIZATION OF NEUROPILIN, A NOVEL VEGF RECEPTOR
|
KLAGSBRUN, MICHAEL
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$683,003
|
|
Cancer
|
NCI
|
5R01CA088986-06
|
|
A fully synthetic carbohydrate-based cancer vaccine
|
BOONS, GEERT-JAN
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$338,098
|
|
Cancer
|
NIDDK
|
5R01DK065961-05
|
|
Estrogen Receptor, MTA3, and Transcriptional Repression
|
BOSS, JEREMY
|
EMORY UNIVERSITY
|
GA
|
$250,219
|
|
Cancer
|
NCI
|
5R01CA072877-09
|
|
The role of SEPT9 in cell proliferation and oncogenesis
|
PETTY, ELIZABETH
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$296,021
|
|
Cancer
|
NCI
|
5R01CA107454-04
|
|
Role of Plcg1 in Vegf signaling
|
LAWSON, NATHAN
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$304,307
|
|
Cancer
|
NCI
|
5R01CA101837-04
|
|
MnSOD-PL Irradiation Protection of the Oral Cavity
|
GREENBERGER, JOEL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$230,171
|
|
Cancer
|
NCI
|
5R01CA106312-04
|
|
Cellular Responses to Cancer Drug-Induced Genomic Breaks
|
BEERMAN, TERRY
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$276,484
|
|
Cancer
|
NIAID
|
5R01AI063058-04
|
|
Roles of the Artemis nuclease in DNA repair and disease
|
SEKIGUCHI, JOANN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$279,700
|
|
Cancer
|
NIGMS
|
5R01GM024663-31
|
|
Genetic Analysis of Nematode Egg Laying
|
HORVITZ, H
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$410,805
|
|
Cancer
|
NCI
|
5R01CA093632-07
|
|
Role of SMC1 Phosphorylation in Radiation Responses
|
KASTAN, MICHAEL
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$309,138
|
|
Cancer
|
NIGMS
|
5R01GM057479-09
|
|
Roles of DNA Ligase 1 in Mammalian DNA Metabolism
|
TOMKINSON, ALAN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$197,127
|
|
Cancer
|
NCI
|
5R01CA111778-04
|
|
Molecular Studies of Down Syndrome Leukemia
|
PERENTESIS, JOHN
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$231,698
|
|
Cancer
|
NIDDK
|
5R37DK051193-13
|
|
Role of U19/Eaf2 in androgen-dependent prostate homeostasis
|
WANG, ZHOU
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$289,685
|
|
Cancer
|
NHLBI
|
5R01HL054977-11
|
|
Molecular Immunology of Minor Histocompatibility Antigen
|
JOYCE, SEBASTIAN
|
VANDERBILT UNIVERSITY
|
TN
|
$372,621
|
|
Cancer
|
NIAID
|
5R01AI039657-12
|
|
Structure-function analysis of H. pylori VacA
|
COVER, TIMOTHY
|
VANDERBILT UNIVERSITY
|
TN
|
$346,156
|
|
Cancer
|
NHLBI
|
5R37HL051045-12
|
|
Protection against Doxorubicin-Induced Cardiomyopathy
|
KUKREJA, RAKESH
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$357,248
|
|
Cancer
|
NIDDK
|
5K23DK066165-05
|
|
Screening for Barrett's in Otolaryngology Patients
|
JOBE, BLAIR
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$133,110
|
|
Cancer
|
NCI
|
5R01CA112519-03
|
|
Novel Targeted Therapeutics for Cental Nervous System Malignancies
|
ALI-OSMAN, FRANCIS
|
DUKE UNIVERSITY
|
NC
|
$327,069
|
|
Cancer
|
NCI
|
5R01CA100226-05
|
|
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
|
CAMPBELL, KERRY
|
INSTITUTE FOR CANCER RESEARCH
|
PA
|
$262,798
|
|
Cancer
|
NCI
|
5R01CA125554-02
|
|
Mechanisms of estrogen action on bone marrow-derived stem stromal cells
|
KUPERWASSER, CHARLOTTE
|
TUFTS UNIVERSITY BOSTON
|
MA
|
$310,650
|
|
Cancer
|
NCI
|
5R01CA084360-09
|
|
Tumor and Stromal Metalloproteinases in Breast Cancer
|
MATRISIAN, LYNN
|
VANDERBILT UNIVERSITY
|
TN
|
$408,553
|
|
Cancer
|
NCI
|
5R01CA082577-09
|
|
Role of p53 Missense Mutations on Tumorigenesis in Vivo
|
LOZANO, GUILLERMINA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$256,010
|
|
Cancer
|
NCI
|
5R01CA106491-04
|
|
Cardiolipin in Photodynamic Therapy
|
OLEINICK, NANCY
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$237,918
|
|
